Gain Therapeutics

+$0.06 (+2.22%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GANX and other ETFs, options, and stocks.

About GANX

Gain Therapeutics, Inc. is a redefining drug discovery company, which identifies and optimizes allosteric binding sites that never before targeted. Its See-Tx target identification platform uses the published 3D structure of enzymes and a proprietary computational technology to discover new allosteric binding sites and predict their druggability.

CEO
Eric I. Richman
Employees
25
Headquarters
Bethesda, Maryland
Founded
2017

GANX Key Statistics

Market cap
32.80M
Price-Earnings ratio
—
Dividend yield
—
Average volume
105.13K
High today
$3.12
Low today
$2.70
Open price
$2.75
Volume
251.50K
52 Week high
$11.00
52 Week low
$2.53

GANX Earnings

-$0.50
-$0.40
-$0.29
-$0.19
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.37 per share
Actual
-$0.28 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure